Client Communications - Prime Therapeutics

Members
Client Resources
Pharmacy + Provider Resources
Drug Recalls
Events

Who we are
Our solutions
Read, watch, listen
Pharmacy
Careers

Members
Client Resources
Pharmacy + Provider Resources
Drug Recalls
Events

Home
Client Communication
Client Communications

Explore what's trending at Prime

https://primetherapeutics.com/w/new-reporting-confirms-smart-edits-reduces-prior-authorization-costs-for-glp-1s-and-other-drugs Example Link

Client news

New reporting confirms Smart Edits reduces Prior Authorization costs for GLP-1s and other drugs

February 18, 2025

https://primetherapeutics.com/w/cvs-costvantage-overview-and-what-it-means-to-prime-clients Example Link

Client news

CVS CostVantage overview and what it means to Prime clients

February 26, 2025

https://primetherapeutics.com/w/simplicityrx-medicare-m3p-portal-issue-resolved-funds-transfer-reconciliation-delayed Example Link

Client news

SimplicityRx Medicare M3P Portal Issue Resolved - Funds Transfer & Reconciliation Delayed

February 24, 2025

https://primetherapeutics.com/w/m3p-enhanced-daily-monitoring-program-effective-feb-24 Example Link

Client news

M3P enhanced daily monitoring program, effective Feb. 24

February 24, 2025

The Latest

Categories

CC Sub-Categories

https://primetherapeutics.com/w/cvs-costvantage-overview-and-what-it-means-to-prime-clients

Client news

CVS CostVantage overview and what it means to Prime clients

February 26, 2025

https://primetherapeutics.com/w/simplicityrx-medicare-m3p-portal-issue-resolved-funds-transfer-reconciliation-delayed

Client news

SimplicityRx Medicare M3P Portal Issue Resolved - Funds Transfer & Reconciliation Delayed

February 24, 2025

https://primetherapeutics.com/w/m3p-enhanced-daily-monitoring-program-effective-feb-24

Client news

M3P enhanced daily monitoring program, effective Feb. 24

February 24, 2025

https://primetherapeutics.com/w/arkansas-rule-128-reporting-requirements

Client news

Arkansas Rule 128 reporting requirements

February 24, 2025

https://primetherapeutics.com/w/new-reporting-confirms-smart-edits-reduces-prior-authorization-costs-for-glp-1s-and-other-drugs

Client news

New reporting confirms Smart Edits reduces Prior Authorization costs for GLP-1s and other drugs

February 18, 2025

https://primetherapeutics.com/w/read-featured-drug-insights-february-2025

Client news

READ: Featured Drug Insights: February 2025

February 18, 2025

https://primetherapeutics.com/w/read-ira-faq-updates-february-2025

Client news

READ: IRA FAQ updates - February 2025

February 12, 2025

https://primetherapeutics.com/w/read-esi-to-begin-dispensing-glp-1-drugs-to-new-to-therapy-members-1

Client news

READ: ESI to begin dispensing GLP-1 drugs to new-to-therapy members

February 06, 2025

https://primetherapeutics.com/w/prime-s-dei-program-focuses-on-welcomeness-inclusivity-2

Client news

Prime’s DEI program focuses on welcomeness, inclusivity

February 04, 2025

Showing 1 to 9 of 81

Categories

CC Sub-Categories

https://primetherapeutics.com/w/read-featured-drug-insights-february-2025

Client news

READ: Featured Drug Insights: February 2025

February 18, 2025

https://primetherapeutics.com/w/prime-s-dei-program-focuses-on-welcomeness-inclusivity-2

Client news

Prime’s DEI program focuses on welcomeness, inclusivity

February 04, 2025

https://primetherapeutics.com/w/read-featured-drug-insights-january-2025

Client news

READ: Featured Drug Insights: January 2025

January 31, 2025

https://primetherapeutics.com/w/read-ftc-second-interim-report-key-insights-and-information-2-1

Client news

READ: FTC second interim report: Key insights and information

January 16, 2025

https://primetherapeutics.com/w/updates-to-glp-1s-and-maintenance-indicator-for-mid-market-clients

Client news

Updates to GLP-1s and Prime's standard maintenance drug list used by mid-market clients

January 08, 2025

https://primetherapeutics.com/w/read-severe-weather-preparedness-wildfires-and-winter-storms

Client news

READ: Severe weather preparedness – wildfires and winter storms

January 08, 2025

https://primetherapeutics.com/w/read-for-awareness-walgreens-are-limiting-glp-1s-to-one-month-supply

Client news

READ: For awareness, Walgreens are limiting GLP-1s to one-month supply

December 31, 2025

https://primetherapeutics.com/w/read-featured-drug-insights-december-2024

Client news

READ: Featured Drug Insights: December 2024

December 30, 2025

https://primetherapeutics.com/w/hipaa-privacy-rule-supports-reproductive-health-care-privacy

Client news

HIPAA privacy rule supports reproductive health care privacy

December 10, 2024

Showing 1 to 9 of 37

Categories

CC Sub-Categories

https://primetherapeutics.com/w/read-featured-drug-insights-february-2025

Client news

READ: Featured Drug Insights: February 2025

February 18, 2025

https://primetherapeutics.com/w/prime-s-dei-program-focuses-on-welcomeness-inclusivity-2

Client news

Prime’s DEI program focuses on welcomeness, inclusivity

February 04, 2025

https://primetherapeutics.com/w/read-featured-drug-insights-january-2025

Client news

READ: Featured Drug Insights: January 2025

January 31, 2025

https://primetherapeutics.com/w/read-ftc-second-interim-report-key-insights-and-information-2-1

Client news

READ: FTC second interim report: Key insights and information

January 16, 2025

https://primetherapeutics.com/w/read-severe-weather-preparedness-wildfires-and-winter-storms

Client news

READ: Severe weather preparedness – wildfires and winter storms

January 08, 2025

https://primetherapeutics.com/w/read-for-awareness-walgreens-are-limiting-glp-1s-to-one-month-supply

Client news

READ: For awareness, Walgreens are limiting GLP-1s to one-month supply

December 31, 2025

https://primetherapeutics.com/w/read-featured-drug-insights-december-2024

Client news

READ: Featured Drug Insights: December 2024

December 30, 2025

https://primetherapeutics.com/w/hipaa-privacy-rule-supports-reproductive-health-care-privacy

Client news

HIPAA privacy rule supports reproductive health care privacy

December 10, 2024

https://primetherapeutics.com/w/read-featured-drug-insights-november-2024

Client news

READ: Featured Drug Insights: November 2024

November 27, 2024

Showing 1 to 9 of 59

Categories

CC Sub-Categories

https://primetherapeutics.com/w/read-featured-drug-insights-february-2025

Client news

READ: Featured Drug Insights: February 2025

February 18, 2025

https://primetherapeutics.com/w/prime-s-dei-program-focuses-on-welcomeness-inclusivity-2

Client news

Prime’s DEI program focuses on welcomeness, inclusivity

February 04, 2025

https://primetherapeutics.com/w/read-featured-drug-insights-january-2025

Client news

READ: Featured Drug Insights: January 2025

January 31, 2025

https://primetherapeutics.com/w/read-ftc-second-interim-report-key-insights-and-information-2-1

Client news

READ: FTC second interim report: Key insights and information

January 16, 2025

https://primetherapeutics.com/w/read-severe-weather-preparedness-wildfires-and-winter-storms

Client news

READ: Severe weather preparedness – wildfires and winter storms

January 08, 2025

https://primetherapeutics.com/w/read-for-awareness-walgreens-are-limiting-glp-1s-to-one-month-supply

Client news

READ: For awareness, Walgreens are limiting GLP-1s to one-month supply

December 31, 2025

https://primetherapeutics.com/w/read-featured-drug-insights-december-2024

Client news

READ: Featured Drug Insights: December 2024

December 30, 2025

https://primetherapeutics.com/w/read-featured-drug-insights-november-2024

Client news

READ: Featured Drug Insights: November 2024

November 27, 2024

https://primetherapeutics.com/w/read-mandatory-sensitivity-labels-begin-nov-14-1

Client news

READ: Mandatory sensitivity labels begin Nov. 14

November 04, 2024

Showing 1 to 9 of 41

Categories

CC Sub-Categories

https://primetherapeutics.com/w/read-featured-drug-insights-february-2025 Example Link

Client news

READ: Featured Drug Insights: February 2025

February 18, 2025

https://primetherapeutics.com/w/prime-s-dei-program-focuses-on-welcomeness-inclusivity-2 Example Link

Client news

Prime’s DEI program focuses on welcomeness, inclusivity

February 04, 2025

https://primetherapeutics.com/w/read-featured-drug-insights-january-2025 Example Link

Client news

READ: Featured Drug Insights: January 2025

January 31, 2025

https://primetherapeutics.com/w/read-ftc-second-interim-report-key-insights-and-information-2-1 Example Link

Client news

READ: FTC second interim report: Key insights and information

January 16, 2025

https://primetherapeutics.com/w/read-severe-weather-preparedness-wildfires-and-winter-storms Example Link

Client news

READ: Severe weather preparedness – wildfires and winter storms

January 08, 2025

https://primetherapeutics.com/w/read-for-awareness-walgreens-are-limiting-glp-1s-to-one-month-supply Example Link

Client news

READ: For awareness, Walgreens are limiting GLP-1s to one-month supply

December 31, 2025

https://primetherapeutics.com/w/read-featured-drug-insights-december-2024 Example Link

Client news

READ: Featured Drug Insights: December 2024

December 30, 2025

https://primetherapeutics.com/w/read-stars-and-bid-forum-prime-s-medicare-clients-lead-the-way-1 Example Link

Client news

READ: Stars and Bid Forum: Prime's Medicare clients lead the way

December 19, 2024

https://primetherapeutics.com/w/hipaa-privacy-rule-supports-reproductive-health-care-privacy Example Link

Client news

HIPAA privacy rule supports reproductive health care privacy

December 10, 2024

Showing 1 to 9 of 48

Login Portals

Members and Consumers
Clients and Health Plans
Pharmacy + Provider Resources

Compliance / Legal

Privacy Policy
Notice of Privacy Practices
Terms of Use
Nondiscrimination + Languages
Subrogation

Careers

Careers Overview

Client Communications - Prime Therapeutics

About us

Corporate social responsibility

Solutions overview

Modern technology

Drug access

Clinical solutions

Condition management

Specialty drug management

Government solutions

Single-state programs

Read

Watch

Listen

Home Delivery

Specialty Pharmacy

Navigate to

Back

Back

Back

Back

Explore what's trending at Prime

New reporting confirms Smart Edits reduces Prior Authorization costs for GLP-1s and other drugs

CVS CostVantage overview and what it means to Prime clients

SimplicityRx Medicare M3P Portal Issue Resolved - Funds Transfer & Reconciliation Delayed

M3P enhanced daily monitoring program, effective Feb. 24

The Latest

CVS CostVantage overview and what it means to Prime clients

SimplicityRx Medicare M3P Portal Issue Resolved - Funds Transfer & Reconciliation Delayed

M3P enhanced daily monitoring program, effective Feb. 24

Arkansas Rule 128 reporting requirements

New reporting confirms Smart Edits reduces Prior Authorization costs for GLP-1s and other drugs

READ: Featured Drug Insights: February 2025

READ: IRA FAQ updates - February 2025

READ: ESI to begin dispensing GLP-1 drugs to new-to-therapy members

Prime’s DEI program focuses on welcomeness, inclusivity

READ: Featured Drug Insights: February 2025

Prime’s DEI program focuses on welcomeness, inclusivity

READ: Featured Drug Insights: January 2025

READ: FTC second interim report: Key insights and information

Updates to GLP-1s and Prime's standard maintenance drug list used by mid-market clients

READ: Severe weather preparedness – wildfires and winter storms

READ: For awareness, Walgreens are limiting GLP-1s to one-month supply

READ: Featured Drug Insights: December 2024

HIPAA privacy rule supports reproductive health care privacy

READ: Featured Drug Insights: February 2025

Prime’s DEI program focuses on welcomeness, inclusivity

READ: Featured Drug Insights: January 2025

READ: FTC second interim report: Key insights and information

READ: Severe weather preparedness – wildfires and winter storms

READ: For awareness, Walgreens are limiting GLP-1s to one-month supply

READ: Featured Drug Insights: December 2024

HIPAA privacy rule supports reproductive health care privacy

READ: Featured Drug Insights: November 2024

READ: Featured Drug Insights: February 2025

Prime’s DEI program focuses on welcomeness, inclusivity

READ: Featured Drug Insights: January 2025

READ: FTC second interim report: Key insights and information

READ: Severe weather preparedness – wildfires and winter storms

READ: For awareness, Walgreens are limiting GLP-1s to one-month supply

READ: Featured Drug Insights: December 2024

READ: Featured Drug Insights: November 2024

READ: Mandatory sensitivity labels begin Nov. 14

READ: Featured Drug Insights: February 2025

Prime’s DEI program focuses on welcomeness, inclusivity

READ: Featured Drug Insights: January 2025

READ: FTC second interim report: Key insights and information

READ: Severe weather preparedness – wildfires and winter storms

READ: For awareness, Walgreens are limiting GLP-1s to one-month supply

READ: Featured Drug Insights: December 2024

READ: Stars and Bid Forum: Prime's Medicare clients lead the way

HIPAA privacy rule supports reproductive health care privacy

Login Portals

Compliance / Legal

Careers